Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
Open Access
- 1 September 1983
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 80 (17) , 5407-5411
- https://doi.org/10.1073/pnas.80.17.5407
Abstract
Monoclonal antibody 9.2.27 (mAb 9.2.27) directed to a chondroitin sulfate proteoglycan on human melanoma cells was able to suppress tumor growth in athymic (nu/nu) mice more effectively when bound with polyethylene glycol to murine effector cells than when injected alone. These "armed" effector cells also proved more effective than the monoclonal antibody in eliciting antibody-dependent cellular cytotoxicity against human melanoma target cells in vitro.This publication has 23 references indexed in Scilit:
- A rapid technique for isolation of viable tumor cells from solid tumors: Use of the tumor cells for induction and measurement of cell-mediated cytotoxic responsesEuropean Journal of Cancer and Clinical Oncology, 1982
- IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.Proceedings of the National Academy of Sciences, 1982
- PHASE-I CLINICAL TRIAL OF MONOCLONAL ANTIBODY IN TREATMENT OF GASTROINTESTINAL TUMOURSThe Lancet, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- ADCC of Cultured Human Melanoma Cells: Analysis with Monoclonal Antibodies to Human Melanoma-associated AntigensScandinavian Journal of Immunology, 1981
- Production and Characterization of Monoclonal Antibody to a Melanoma Specific GlycoproteinHybridoma, 1981
- Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinomaEuropean Journal of Immunology, 1979
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978
- Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreasInternational Journal of Cancer, 1975